• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰产大肠埃希菌菌血症患者的 30 天全因死亡率。

Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.

机构信息

Healthcare Associated Infection and Antimicrobial Resistance Department, Public Health England, Colindale, London, UK.

Healthcare Associated Infection and Antimicrobial Resistance Department, Public Health England, Colindale, London, UK.

出版信息

Clin Microbiol Infect. 2015 Mar;21(3):251.e1-8. doi: 10.1016/j.cmi.2015.01.001. Epub 2015 Jan 14.

DOI:10.1016/j.cmi.2015.01.001
PMID:25698659
Abstract

Escherichia coli is the commonest cause of bacteraemia in England, with an incidence of 50.7 cases per 100 000 population in 2011. We undertook a large national study to estimate and identify risk factors for 30-day all-cause mortality in E. coli bacteraemia patients. Records for patients with E. coli bacteraemia reported to the English national mandatory surveillance system between 1 July 2011 and 30 June 2012 were linked to death registrations to determine 30-day all-cause mortality. A multivariable regression model was used to identify factors associated with 30-day all-cause mortality. There were 5220 deaths in 28 616 E. coli bacteraemia patients, a mortality rate of 18.2% (95% CI 17.8-18.7%). Three-quarters of deaths occurred within 14 days of specimen collection. Factors independently associated with increased mortality were: age < 1 year or > 44 years; an underlying respiratory or unknown infection focus; ciprofloxacin non-susceptibility; hospital-onset infection or not being admitted; and bacteraemia occurring in the winter. Female gender and a urogenital focus were associated with a reduction in mortality. This is the first national study of mortality among E. coli bacteraemia patients in England. Interventions to reduce mortality need to be multifaceted and include both primary and secondary healthcare providers. Greater awareness of the risk factors for and symptoms of E. coli bacteraemia may prompt earlier diagnosis and treatment. Changes in antimicrobial resistance patterns need to be monitored for their potential impact on infection and mortality.

摘要

大肠埃希菌是英格兰血源性感染最常见的病原体,2011 年发病率为每 10 万人中有 50.7 例。我们进行了一项大型全国性研究,旨在评估和确定大肠埃希菌血源性感染患者 30 天全因死亡率的危险因素。将 2011 年 7 月 1 日至 2012 年 6 月 30 日期间向英国国家强制性监测系统报告的大肠埃希菌血源性感染患者的记录与死亡登记数据相链接,以确定 30 天全因死亡率。采用多变量回归模型确定与 30 天全因死亡率相关的因素。在 28616 例大肠埃希菌血源性感染患者中,有 5220 例死亡,死亡率为 18.2%(95%CI 17.8-18.7%)。四分之三的死亡发生在采集标本后 14 天内。与死亡率增加独立相关的因素包括:年龄<1 岁或>44 岁;存在基础呼吸道或未知感染病灶;对环丙沙星耐药;医院获得性感染或未入院;以及冬季发生血源性感染。女性和泌尿生殖道感染病灶与死亡率降低相关。这是英国首次对大肠埃希菌血源性感染患者死亡率进行的全国性研究。需要采取多方面措施来降低死亡率,包括初级和二级医疗保健提供者。提高对大肠埃希菌血源性感染的风险因素和症状的认识,可能会促使更早地进行诊断和治疗。需要监测抗菌药物耐药性模式的变化,以了解其对感染和死亡率的潜在影响。

相似文献

1
Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.英格兰产大肠埃希菌菌血症患者的 30 天全因死亡率。
Clin Microbiol Infect. 2015 Mar;21(3):251.e1-8. doi: 10.1016/j.cmi.2015.01.001. Epub 2015 Jan 14.
2
Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.2012年4月至2014年3月英格兰大肠杆菌菌血症的描述性流行病学
Euro Surveill. 2016 Sep 1;21(35). doi: 10.2807/1560-7917.ES.2016.21.35.30329.
3
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.加拿大一个大区域内大肠杆菌血流感染的发病率、危险因素及转归
Clin Microbiol Infect. 2008 Nov;14(11):1041-7. doi: 10.1111/j.1469-0691.2008.02089.x.
4
Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.荷兰大肠杆菌菌血症患者中对环丙沙星和庆大霉素耐药性增加的临床后果。
Scand J Infect Dis. 2012 May;44(5):363-8. doi: 10.3109/00365548.2011.641506. Epub 2011 Dec 27.
5
Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.影响大肠埃希菌菌血症负担的因素:2011-2015 年伦敦西部多变量回归分析数据
J Hosp Infect. 2019 Feb;101(2):120-128. doi: 10.1016/j.jhin.2018.10.024. Epub 2018 Nov 4.
6
Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.社区获得性大肠杆菌菌血症中医疗保健相关感染的临床意义
J Antimicrob Chemother. 2007 Dec;60(6):1355-60. doi: 10.1093/jac/dkm378. Epub 2007 Oct 8.
7
Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21.估算 2020/21 年英格兰大肠埃希菌菌血症的发病率和 30 天全因死亡率。
J Hosp Infect. 2018 Mar;98(3):228-231. doi: 10.1016/j.jhin.2017.09.021. Epub 2017 Sep 30.
8
Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men.来自英国菌血症患者的耐环丙沙星大肠杆菌;日益普遍且大多来自男性。
J Antimicrob Chemother. 2003 Dec;52(6):1040-2. doi: 10.1093/jac/dkg479. Epub 2003 Oct 29.
9
Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme.英格兰大肠杆菌菌血症的流行病学:强化哨点监测计划的结果
J Hosp Infect. 2017 Apr;95(4):365-375. doi: 10.1016/j.jhin.2016.12.008. Epub 2016 Dec 16.
10
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.抗生素耐药性及适当的经验性抗生素治疗对大肠杆菌菌血症患者预后的影响。
J Antimicrob Chemother. 2007 Oct;60(4):855-63. doi: 10.1093/jac/dkm279. Epub 2007 Jul 20.

引用本文的文献

1
Clinical Predictors of Versus Bacteremia at the Emergency Department.急诊科菌血症与[未提及内容]的临床预测因素。 (注:原文中“Versus”后面似乎缺失了部分关键信息)
Antibiotics (Basel). 2025 Jun 27;14(7):654. doi: 10.3390/antibiotics14070654.
2
Residence-colonization trade-off and niche differentiation enable coexistence of Escherichia coli phylogroups in healthy humans.居住-定殖权衡与生态位分化使大肠杆菌菌群在健康人体内共存。
ISME J. 2025 Jan 2;19(1). doi: 10.1093/ismejo/wraf089.
3
Preventing and managing urinary tract infections: Exploring interventions and strategies implemented by NHS commissioning organisations in English primary care, 2017-2022.
预防和管理尿路感染:探索英国国家医疗服务体系委托机构在2017 - 2022年英国初级医疗保健中实施的干预措施和策略。
J Infect Prev. 2025 Mar 29:17571774251330536. doi: 10.1177/17571774251330536.
4
Evaluation of the Bacterial Infections and Antibiotic Prescribing Practices in the Intensive Care Unit of a Clinical Hospital in Romania.罗马尼亚一家临床医院重症监护病房细菌感染及抗生素处方实践评估
Antibiotics (Basel). 2025 Jan 9;14(1):64. doi: 10.3390/antibiotics14010064.
5
The epidemiology of gram-negative bacteremia in Lebanon: a study in four hospitals.黎巴嫩革兰氏阴性菌菌血症的流行病学:四家医院的研究。
Ann Clin Microbiol Antimicrob. 2024 Oct 9;23(1):90. doi: 10.1186/s12941-024-00740-0.
6
Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia.模拟窄谱与广谱抗生素在大肠杆菌菌血症经验性治疗中的应用。
Sci Rep. 2024 Jul 23;14(1):16986. doi: 10.1038/s41598-024-66193-9.
7
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.ExPEC10V疫苗在有尿路感染病史的成年人中进行的一项随机1/2a期试验。
NPJ Vaccines. 2024 Jun 14;9(1):106. doi: 10.1038/s41541-024-00885-1.
8
Sex-related immunity: could Toll-like receptors be the answer in acute inflammatory response?性别相关免疫:Toll 样受体是否能成为急性炎症反应的答案?
Front Immunol. 2024 May 21;15:1379754. doi: 10.3389/fimmu.2024.1379754. eCollection 2024.
9
Comparative epidemiology of bacteraemia in two ageing populations: Singapore and Denmark.中老年人菌血症的比较流行病学:新加坡和丹麦。
Epidemiol Infect. 2024 Apr 29;152:e74. doi: 10.1017/S0950268824000645.
10
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.住院老年患者侵袭性大肠埃希菌病的临床表现和抗菌药物耐药性:一项前瞻性多国观察性研究。
Infection. 2024 Jun;52(3):1073-1085. doi: 10.1007/s15010-023-02163-z. Epub 2024 Jan 25.